Riskpilot← Back to searchSign inGet full accessGBG MeDuo AB
ABActiveOrg 5592889694Utlandagatan 10General medical practice activities · NACE 8621Est. 20201 employees
Revenue 2025
SEK 8K
+3233% vs 2024
EBITDA margin
-145.2%
+84% vs 2024
Equity ratio
15.9%
Financial strength
Net profit 2025
SEK -11K
+84% vs 2024
| Revenue | SEK 8K | +3233% |
| EBITDA | SEK -12K | +84% |
| Net profit | SEK -11K | +84% |
| Total assets | SEK 100K | +24% |
| Equity | SEK 16K | -42% |
| Employees | 1 | — |
Legal name
GBG MeDuo AB
Org number
5592889694
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
10 december 2020
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Konsultverksamhet inom medicinsk läkarvård.
Address
Utlandagatan 10
Email
dajanadzeko@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 264 | 213 | 267 | 0 | 8 |
| Staff expenses | — | −0 | −6 | −1 | −0 |
| EBITDA | 252 | 149 | 198 | −71 | −12 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 252 | 149 | 198 | −71 | −12 |
| Net financials | — | 1 | 3 | 1 | 0 |
| Profit before tax | 252 | 150 | 202 | −70 | −11 |
| Tax | −54 | −31 | −42 | — | — |
| Net profit | 198 | 119 | 160 | −70 | −11 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 342 | 468 | 282 | 80 | 100 |
| Equity | 223 | 342 | 202 | 27 | 16 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 119 | 125 | 80 | 53 | 84 |
| Total debt | 119 | 125 | 80 | 53 | 84 |
EBITDA margin
-145.2%
This company
15.8%
Market median
-1019% vs market
20212025
Equity ratio
15.9%
This company
38.2%
Market median
-58% vs market
20212025
Return on equity
-71.0%
This company
18.4%
Market median
-486% vs market
20212025
Net profit margin
-141.5%
This company
8.1%
Market median
-1847% vs market
20212025
Asset turnover
0.08×
This company
1.12×
Market median
-93% vs market
20212025
Debt / equity
5.27×
This company
0.62×
Market median
-750% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-12-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2025 | |
| Deputy Board Member | 2025 | |
| Former (1) | ||
| Board of Directors | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of GBG MeDuo AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marko Alavanja | Board of Directors | 0 companies |
| Dajana Dzeko | Board of Directors | 0 companies |
| Hevar Baha Al Dien Hamah Saed | Deputy Board Member | 0 companies |